Ipragliflozin: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
<languages /> | |||
<translate> | |||
{{Pathnav|Medication|Diabetes medication|SGLT2 inhibitor|frame=1}} | {{Pathnav|Medication|Diabetes medication|SGLT2 inhibitor|frame=1}} | ||
{{Short description|Chemical compound}} | {{Short description|Chemical compound}} | ||
| Line 105: | Line 107: | ||
[[Category:SGLT2 inhibitors]] | [[Category:SGLT2 inhibitors]] | ||
[[Category:Fluoroarenes]] | [[Category:Fluoroarenes]] | ||
</translate> | |||